PL423720A1 - Sweetening system of the oral pharmaceutical composition that contains hydrochloride fenspiride and the pharmaceutical composition that contains this system - Google Patents

Sweetening system of the oral pharmaceutical composition that contains hydrochloride fenspiride and the pharmaceutical composition that contains this system

Info

Publication number
PL423720A1
PL423720A1 PL423720A PL42372017A PL423720A1 PL 423720 A1 PL423720 A1 PL 423720A1 PL 423720 A PL423720 A PL 423720A PL 42372017 A PL42372017 A PL 42372017A PL 423720 A1 PL423720 A1 PL 423720A1
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
fenspiride
hydrochloride
sweetening
oral pharmaceutical
Prior art date
Application number
PL423720A
Other languages
Polish (pl)
Other versions
PL237234B1 (en
Inventor
Agnieszka Pawlaczyk
Barbara Owczarek
Original Assignee
Medana Pharma Spółka Akcyjna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medana Pharma Spółka Akcyjna filed Critical Medana Pharma Spółka Akcyjna
Priority to PL423720A priority Critical patent/PL237234B1/en
Publication of PL423720A1 publication Critical patent/PL423720A1/en
Publication of PL237234B1 publication Critical patent/PL237234B1/en

Links

Abstract

Zgłoszenie dotyczy układu słodzącego ciekłej doustnej kompozycji farmaceutycznej chlorowodorku fenspirydu, składającego się z sacharozy i rebaudiozydu A, w stosunku wagowym sacharozy do rebaudiozydu A w zakresie od 420:1 do 440:1. Ponadto zgłoszenie odnosi się do kompozycji farmaceutycznej zawierającej wspomniany układ słodzący w ilości od 785 mg/ml do 795 mg/ml kompozycji.The application relates to a sweetener system for the liquid pharmaceutical pharmaceutical composition fenspiride hydrochloride, consisting of sucrose and rebaudioside A, in a weight ratio of sucrose to rebaudioside A in the range from 420: 1 to 440: 1. Furthermore, the application relates to a pharmaceutical composition containing said sweetener system in an amount from 785 mg / ml to 795 mg / ml of the composition.

PL423720A 2017-12-04 2017-12-04 Sweetening system of the oral pharmaceutical composition that contains hydrochloride fenspiride and the pharmaceutical composition that contains this system PL237234B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL423720A PL237234B1 (en) 2017-12-04 2017-12-04 Sweetening system of the oral pharmaceutical composition that contains hydrochloride fenspiride and the pharmaceutical composition that contains this system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL423720A PL237234B1 (en) 2017-12-04 2017-12-04 Sweetening system of the oral pharmaceutical composition that contains hydrochloride fenspiride and the pharmaceutical composition that contains this system

Publications (2)

Publication Number Publication Date
PL423720A1 true PL423720A1 (en) 2019-06-17
PL237234B1 PL237234B1 (en) 2021-03-22

Family

ID=66809703

Family Applications (1)

Application Number Title Priority Date Filing Date
PL423720A PL237234B1 (en) 2017-12-04 2017-12-04 Sweetening system of the oral pharmaceutical composition that contains hydrochloride fenspiride and the pharmaceutical composition that contains this system

Country Status (1)

Country Link
PL (1) PL237234B1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110236551A1 (en) * 2010-03-16 2011-09-29 Imperial Sugar Company Process for the manufacture of co-crystallized sucrose natural sweeteners and the products thereof
US20150237907A1 (en) * 2006-10-24 2015-08-27 Givaudan S.A. Consumables

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150237907A1 (en) * 2006-10-24 2015-08-27 Givaudan S.A. Consumables
US20110236551A1 (en) * 2010-03-16 2011-09-29 Imperial Sugar Company Process for the manufacture of co-crystallized sucrose natural sweeteners and the products thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PULNEO, PULNEO, SYROP FENSPIRIDI HYDROCHLORIDUM 2MG/ML *
WOJCIECH KOLANOWSKI, GLIKOZYDY STEWIOLOWE - WŁAŚCIWOŚCI I ZASTOSOWANIE W ŻYWNOŚCI, 2013 *

Also Published As

Publication number Publication date
PL237234B1 (en) 2021-03-22

Similar Documents

Publication Publication Date Title
NZ763551A (en) Compounds useful for inhibiting cdk7
BR112017028517A2 (en) "pharmaceutical composition, vector, peptide, polynucleotide and isolated conjugate and composition"
DK3328843T3 (en) 1,3,4-OXADIAZOLESULFONAMIDE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE-6 INHIBITORS AND THE PHARMACEUTICAL COMPOSITION
NZ743964A (en) Aqueous pharmaceutical formulation comprising anti-pd-1 antibody avelumab
PH12016501310A1 (en) Pharmaceutical compositions comprising azd9291
WO2015061572A8 (en) Inhibitors of the fibroblast growth factor receptor
UA111343C2 (en) Pharmaceutical composition for nasal administration comprising mometasone furoate and azelastine hydrochloride
NZ712270A (en) Pharmaceutical composition of s-ketamine hydrochloride
PH12018500627A1 (en) Compounds and compositions for the treatment of ocular disorders
MX2017015879A (en) Hydroxypropyl beta-cyclodextrin compositions and methods.
MX2021004000A (en) Piperidine cxcr7 receptor modulators.
PH12015502632A1 (en) Cxcr7 receptor modulators
EA202090732A1 (en) TRANSDERMAL ADMINISTRATION FORMULATIONS
IL282163A (en) Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or its salt
IL285421A (en) Indazolyl-isoxazole derivatives, their preparation and pharmaceutical compositions containing them
WO2019054891A3 (en) Trpv2 antagonists
EA201890202A1 (en) NATURAL STYLBENES AS SWEETS OR AMPLIFIERS OF SWEETS
EA201892842A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING SAFINAMID
PL423720A1 (en) Sweetening system of the oral pharmaceutical composition that contains hydrochloride fenspiride and the pharmaceutical composition that contains this system
MX2017015202A (en) Liquid formulations of celecoxib for oral administration.
EA202091403A1 (en) 2-OXO-1-PYRROLIDINYLIMIDAZOTHIAZOLE DERIVATIVES
PT3845230T (en) Pharmaceutical composition for oral administration
ECSP19024033A (en) THESOPHENSIN COMPOSITIONS
EA201500446A1 (en) PHARMACEUTICAL COMPOSITION TO REDUCE N-OXIDE TRIMETYLAMINE LEVEL
NO20085267L (en) Derivatives of 2-alkoxy -3,4,5-trihydroxyalkyl amides, preparation and use thereof, as well as compositions containing the same